Feasibility study of adjuvant chemotherapy with combination Docetaxel AND Daily Oral Cyclophosphamide for Japanese breast cancer patients.
- Conditions
- Breast Cancer
- Registration Number
- JPRN-UMIN000006673
- Lead Sponsor
- Shiga University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 20
Not provided
1. Bilateral breast cancer in same time 2. Active double cancer 3. Inflammatory breast cancer 4. Male breast cancer 5. Severe drug allergic history 6. Severe complications (i.e. ischemic heart diseases required treatment, arrhythmia, myocardial infartion within 6 months, liver cirrhosis, uncontrolled diabetes, hemorrhagic tendency) 7. Active infections 8. Peripheral nerve disorders 9. Massive pleural or pericardial effusion 10. Severe edema 11. Interstitial lung disease, pulmonary fibrosis 12. The case which has an underlying disease which needs combined use with steroid 13. Psychiatric disease 14. Pregnant or lactating women 15. Other conditions not suitable for this study 16. Allergy against polysorbert 80
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility
- Secondary Outcome Measures
Name Time Method Safety, Disease-free survival